February 6, 2023
Contract Pharma
Bristol Myers Squibb 4Q Results
Results impacted by loss of exclusivity primarily for Revlimid, partially offset by Opdivo and new pr... See more »
February 6, 2023
Contract Pharma
February 7, 2023
Nasdaq
February 6, 2023
Contract Pharma
February 7, 2023
Nasdaq
CEO
Aesthetics BioMedical develops and distributes skin care products.
Read more